Johannesburg - Chris Aucamp has resigned as Chief Financial Officer and executive director of Cipla Medpro with immediate effect‚ the company said Monday.
Aucamp has agreed to remain in the employment of the subsidiary Medpro Pharmaceutica Proprietary Limited‚ where he will remain as a director‚ until at least 31 March 2013.
He will provide assistance to Cipla Medpro‚ as required‚ with regard to the finalisation of the 2012 year-end audit and annual financial statements as well as a hand over to the new Chief Financial Officer‚ the company said.
Mark Daly has been appointed as the Chief Financial Officer of Cipla Medpro and as an executive director of the company with effect from 26 November 2012.
Daly is a chartered accountant and holds a B.Com Honours degree in accounting from the University of Natal Pietermaritzburg. He currently serves as Company Secretary for Cipla Medpro and Financial Director of the manufacturing division in Durban.
Daly has been with the Cipla Medpro group for almost 6 years and prior to that he was a manager in the Corporate Finance and
Auditing departments at KPMG.
The appointment of a new company secretary will be announced in due course.